Related references
Note: Only part of the references are listed.Cathelicidin LL-37: A Multitask Antimicrobial Peptide
Robert Bucki et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
Katarzyna Leszczynska et al.
BMC MICROBIOLOGY (2009)
Effect of sphingosine 1-phosphate on morphological and functional responses in endothelia and venules after scalding injury
Xianglan Liu et al.
BURNS (2009)
Endothelial permeability is controlled by spatially defined cytoskeletal mechanics: Atomic force microscopy force mapping of pulmonary endothelial monolayer
Anna A. Birukova et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity
Jan-Michel Otte et al.
REGULATORY PEPTIDES (2009)
Regulation of endothelial junctional permeability
Emily Vandenbroucke et al.
CONTROL AND REGULATION OF TRANSPORT PHENOMENA IN THE CARDIAC SYSTEM (2008)
Regulation of cell-cell adhesion by the cadherin-catenin complex
W. James Nelson
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Endogenous antimicrobial peptide LL-37 induces human vasodilatation
I. Berkestedt et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner
Linda Tomasinsig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Modulation of P2X7 receptor functions by polymyxin B:: crucial role of the hydrophobic tail of the antibiotic molecule
D. Ferrari et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum
Robert Bucki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Soft biological materials and their impact on cell function
Ilya Levental et al.
SOFT MATTER (2007)
Peptide antimicrobial agents
Havard Jenssen et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Multifunctional roles of human cathelicidin (LL-37) at the ocular surface
Ling C. Huang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7
Isao Nagaoka et al.
JOURNAL OF IMMUNOLOGY (2006)
Signaling mechanisms regulating endothelial permeability
D Mehta et al.
PHYSIOLOGICAL REVIEWS (2006)
Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and α-actinin
PA Singleton et al.
FASEB JOURNAL (2005)
Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood:: Implications for systemic applications
B Deslouches et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Immunomodulatory activities of small host defense peptides
DME Bowdish et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates Rac activation and adherens junction assembly in endothelial cells
D Mehta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Impact of LL-37 on anti-infective immunity
DME Bowdish et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Cell stiffness and receptors: evidence for cytoskeletal subnetworks
H Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
A Elssner et al.
JOURNAL OF IMMUNOLOGY (2004)
Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense
M Murakami et al.
JOURNAL OF IMMUNOLOGY (2004)
Phorbol ester-mediated pulmonary artery endothelial barrier dysfunction through regulation of actin cytoskeletal mechanics
AB Moy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I
YQ Wang et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2004)
Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin
R Bucki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor
GS Tjabringa et al.
JOURNAL OF IMMUNOLOGY (2003)
The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin
DJ Weiner et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
OE Sorensen et al.
BLOOD (2001)
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
D Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Bactericidal activity of mammalian cathelicidin-derived peptides
SM Travis et al.
INFECTION AND IMMUNITY (2000)
Share Paper
